Japan Legal Cannabis Market Size, Share, By Product Type (Flower Buds, Concentrates, Edibles, Oil & Tinctures, Topicals, and Others), Source (Marijuana, and Hemp), Species (Cannabis Sativa, Cannabis Indica, and Cannabis Ruderalis), End-User (Patients, Adult Consumers, Pharmaceutical Companies, Research Institutes, Beauty & Personal Care Industry, and Others)- Trends, Analysis and Forecast till 2035

• By 2035, the Japan legal cannabis market size is contemplated to enlarge at a valuation of USD 9.8 Billion.
• In 2025, the Japan legal cannabis market valuation was USD 0.85 Billion.
• Japan legal cannabis market is developing at a CAGR of 19.73%.

Legal cannabis is a methodical regulated form of cannabis plant used for therapy, entertaining, or industrial purposes, which scientifically converts the substance to a timely-concerted substance into a study and quality-controlled product. Its unique benefits include enabling research on rare cannabinoids for advanced treatments, promoting environmentally friendly innovations such as cannabis-based materials, promoting local economies through job construction, and supporting individual medicine for chronic or treatment-resistant conditions-all involving everyone.

Japan legal cannabis market growth of the is inspired by changes in government approach towards medical cannabis, increasing demand for alternative remedies and increasing public awareness about its possible health benefits. Japan's aging population is also interested in cannabis-based remedies for chronic pain, insomnia and neurological disorders. Additionally, global impact, investment interest and ongoing research cooperation are encouraging regulatory reforms, keeping Japan in position as an emerging player in the Japan Medical Cannabis landscape.

The future of Japan legal cannabis market looks promising, which is powered by recent regulatory reforms, which allows the use of medical cannabis and increasing acceptance of cannabis-based treatments. Along with the support of research and innovation, increasing consumer interest in CBD wellness products is expected to further promote market development. Despite strict control over THC, Japan is ranking himself as a prominent player in the Japan Cannabis landscape to be gradually developed.

Recession Risk and Tariff Analysis:

• Japan legal cannabis market faces some recession related risks, as economic recession can reduce consumer spending on welfare and alternative remedies. However, the effect of tariff is minimal due to Japan's involvement in various free trade agreements, which allows import of medical cannabis products and extracts without any duty. This favorable trade environment supports market growth despite potential economic headwinds.

Impact of Generative AI on Japan Legal Cannabis Market:

• Generative AI is ready to enable Japan legal cannabis market to enhance individual medical remedies, improve product growth through future stating analysis and support regulatory compliance with AI-operated tracking systems.
• It can align with Japan's strict cannabis rules and focus on medical applications, adapt the cultivation of patients through all intelligent support equipment, reduce costs and also help patients.

Key Drivers:

The Growth of the Market is Depend upon Aging Population in the Region

Japan’s rapid aging population is a major driver of development in the legal cannabis market, as elderly people seek alternative treatment for age-related conditions such as chronic pain, arthritis, insomnia and neurodynamic disorders. Medical cannabis, especially non-psychiatry options such as CBD, provide a natural and potential safe solution compared to traditional pharmaceuticals with harsh side effects. Since healthcare provider and policy makers recognize medical benefits for seniors, the demand for legal, regulated cannabis-based treatments in Japan is expected to increase significantly.

• For Instance, according to the data published by World Economic Forum, more than 1 in 10 people in the country are now aged 80 or older, according to the latest national data. Almost a third of its population is over 65 an estimated 36.23 million. And there are more people than ever blowing out 100 birthday candles. Japan consistently has the oldest population in the world – with significantly more people over the age of 65 than Italy, the next oldest country.

Restrains:

The Market Growth is Controlled by Lack of Physician Training on Cannabinoid Treatments

Lack of physician training on cannabinoids remedies in Japan is a significant obstacle to adopt medical cannabis, as most healthcare professionals have performed limited to cannabis related education due to their long-term prohibition. It hesitates to prescribe or recommend cannabinoids-based treatments even when it is legally available.

• Counterbalance Statements: A practical solution is to introduce a continuous education module for the practice of certified medical cannabis education programs and doctors in medical schools, supported by government-backed clinical research and international collaboration. This will create clinical confidence and ensure safe, evidence-based patient care.

Opportunities & Trends:

Technological Integration can Drive Market Growth in Upcoming Years

Technical integration is a major future trend for Japan legal cannabis market, as advanced equipment such as AI, IOT and blockchain expects to increase farming efficiency, product quality and regulatory compliance. These innovations enable accurate monitoring of increasing conditions, automation of farming processes and complete traceability, Japan's strict security standards. Hugging such technology will support scalable, high quality medical cannabis production by reducing costs and increasing confidence between regulators and consumers.

Product type, source, species, end user, are the divisions of the Japan legal cannabis market.

By Product Type:

The product types available in the legal cannabis market in Japan include flower buds, concentrates, edibles, oil and tinctures, topicals, and more. Due to its precise dose, ease of use, and broad acceptance among medical patients for conditions including anxiety, epilepsy, and chronic pain, oils and tinctures have the largest Japan legal cannabis market share.

Flower buds, or dried cannabis flower, account for the second-largest percentage, particularly in countries such as Australia and Thailand where the usage of smokeable or vaporizable cannabis flower for medicinal purposes is expanding.

By Source:

Hemp and marijuana are the sources for which the market is classified. In the Japan legal cannabis industry, hemp-derived products hold the most Japan legal cannabis market share. This is mainly as they are more easily accessible than THC products, they are broadly lawful under many national regulations, and CBD-infused health and cosmetics are expanding quickly.

Although most countries have stricter medical-only regulations and restricted adult-use frameworks, marijuana (THC-containing cannabis) continues to be the second-largest market despite its notable advancement in therapeutic and medicinal purposes.

By Species:

The species found in the legal cannabis market in Japan are cannabis sativa, cannabis indica, and cannabis ruderalis. Cannabis sativa dominates in Japan legal cannabis market size simply owing to its high CBD concentration, which makes it suitable for hemp-based items, which govern the wellness, cosmetic, and therapeutic sectors in the area.

Due to its relaxing and soothing properties, cannabis indica, which ranks second in medical cannabis programs, is commonly administered for pain relief, anxiety, and insomnia.

By End User:

Patients, adult consumers, pharmaceutical firms, research institutions, the beauty and personal care business, and others are the several end-user categories that make up the market. Since medical cannabis programs are the primary means of access for chronic conditions including cancer-related symptoms, anxiety, chronic pain, and epilepsy, patients are the largest end-user segment in the Japan legal cannabis market growth.

Pharmaceutical companies are among the second-largest group; they play a crucial role in clinical research, the creation of standardized cannabis-based medications, and working with healthcare systems to supply prescription-grade, regulated medications

Japan Legal Cannabis Market Report Scope:

Segmentation:

By Product Type:

• Flower Buds
• Concentrates
• Edibles
• Oil & Tinctures
• Topicals
• Others

By Source:

• Marijuana
• Hemp

By Species:

• Cannabis Sativa
• Cannabis Indica
• Cannabis Ruderalis

By End User:

• Patients
• Adult Consumers
• Research Institutes
• Beauty & Personal Care Industry
• Others

Legal cannabis producers in Japan are growing their businesses by focusing on medical cannabis, expanding their CBD wellness lines, investing in pharmaceutical-grade R&D, forming local partnerships, using e-commerce, and localizing farming in order to cut costs and meet regulatory requirements. Endoca, MAJIC, Amber Farm Co., Ltd., Tenrain Co., Ltd., and others are the major companies involved in the legal cannabis market in Japan.

List of Key Players in the Market:

• HealthyTOKYO
• Endoca
• Naturecan JP
• Astrasana Holding AG
• Tenrain Co., Ltd.
• MAJIC
• CHILLAXY

• In October 2024, Experts caution that any attempts to relax some of the harshest laws in the world are still "insufficient," despite the Japanese government's recent issuance of revised guidelines regarding the THC limits un CBD products. After a public consultation earlier this year, Japan's plans to alter its almost century-old cannabis laws are still being developed.

Analyst View:

Due to regulatory changes that permit the use of cannabis for medicinal purposes, an increase in the demand for alternative treatments, and increased public knowledge of the drug's health advantages, Japan's legal cannabis industry is slowly taking shape. Global impact, investment, and research collaboration boost the industry as an aging population looks for treatment from chronic illnesses and interest in CBD wellness products rises. Japan is using scientific advancement and regulated access to cannabis-based therapies to establish itself as a prospective competitor in the Japan cannabis market, despite stringent THC limits.

More Related Reports

Legal Cannabis Market
Medical Cannabis Market
Legal Technology Market
Legal Cannabis Market
Cannabis Extract Market